Resources

Consumer Health Info, Health Info

Menopause and Sexuality

December 29, 2022

By: NWHN Staff

Popular culture tells us that many women lose interest in sex during or after menopausal transition, but those ageist and sexist messages aren’t supported by good scientific research. We want you to have the facts and offer a few helpful remedies.

Consumer Health Info, Health Info

Consumer Health Info: Addyi Health

July 30, 2019

By: Rachel Grimsley, (RN, BSN, MSN) Volunteer Health Officer

Flibanserin (brand name: Addyi) is the first drug approved by the U.S. Food and Drug Administration (FDA) to treat lack of sexual desire (Hypoactive Sexual Desire Disorder) in premenopausal women.

Press Releases

The NWHN’s Statement on the FDA Ordering Sprout Pharmaceuticals to Retain Black Box Label Warning Women Not Mix Addyi and Alcohol

April 12, 2019

By: Cindy Pearson

FOR IMMEDIATE RELEASE Contact: Evita Almassi, [email protected] or (202) 682-6240

Consumer Health Info

Top 10 Things to Know About Today’s Sex Drive Drugs

October 15, 2015

By: Rachel Grimsley, (RN, BSN, MSN) Volunteer Health Officer

Learn about Addyi (flibanserin) and Vyleesi (bremelanotide), FDA-approved drugs designed to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.